Home › Funds › SABBY MANAGEMENT, LLC › ZVRA
SABBY MANAGEMENT, LLC position in ZVRA
ZEVRA THERAPEUTICS INC · Health Care
SABBY MANAGEMENT, LLC reported holding 864 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$376K, representing 8.35% of its reported portfolio and ranking #5 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed ZVRA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SABBY MANAGEMENT, LLC's ZVRA position evolved
SABBY MANAGEMENT, LLC first disclosed a stake in ZVRA in Q4 2024 at 163 shares (US$136K). The position peaked in Q2 2026 at 427 shares, worth US$612K. Across 8 filings, SABBY MANAGEMENT, LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 864 shares valued at US$376K — an increase of 437 shares quarter over quarter.. Notable position changes include a 364% increase in Q1 2025 (shares rose 18% over the following quarter), a 208% increase in Q3 2025 (shares fell 6% over the following quarter), a 102% increase in Q3 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 163 | $135.94K | New |
| Q1 2025 | 756 | $344.80K | Add |
| Q2 2025 | 106 | $93.39K | Reduce |
| Q3 2025 | 327 | $310.98K | Add |
| Q4 2025 | 327 | $292.99K | Hold |
| Q1 2026 | 340 | $316.88K | Add |
| Q2 2026 | 427 | $612.32K | Add |
| Q3 2026 | 864 | $375.84K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZVRA and 13F data
ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), 683 Capital Management, LLC (US$12.3M), KINGDON CAPITAL MANAGEMENT, L.L.C. (US$11.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZVRA
- Nantahala Capital Management, LLC 1.80M sh · $25.78M · Q2 2026
- 683 Capital Management, LLC 855.00K sh · $12.26M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 775.00K sh · $11.11M · Q2 2026
- Retirement Planning Co of New England, Inc. 612.33K sh · $6.72M · Q3 2026
- Mystic Asset Management, Inc. 355.38K sh · $3.90M · Q3 2026
- Stonepine Capital Management, LLC 258.70K sh · $3.71M · Q2 2026
- Diametric Capital, LP 231.47K sh · $3.32M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 200.26K sh · $2.20M · Q3 2026
More on SABBY MANAGEMENT, LLC
FAQ
How long has SABBY MANAGEMENT, LLC held ZVRA?
SABBY MANAGEMENT, LLC has disclosed ZVRA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is SABBY MANAGEMENT, LLC's current position in ZVRA?
As of Q3 2026, SABBY MANAGEMENT, LLC holds 864 shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $375.84K, representing 8.35% of its reported portfolio and ranking #5.
Has SABBY MANAGEMENT, LLC been buying or selling ZVRA?
In the latest 13F filing (Q3 2026), SABBY MANAGEMENT, LLC increased its position in ZVRA. The position peaked in Q2 2026 at 427 shares.
Which other funds hold ZVRA?
Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.